Tokyo Tape
Sign in
← Nihon Parkerizing

Quarterly report · Q1

4095.TEDINET S100ROBA
Period2023-04-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥28.6bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥119.2bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥27.3bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥3.2bn2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥2.9bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥4.3bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥16.6bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥4.2bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥4.3bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥4.3bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥2.7bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥10.0bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.5bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥3.2bn2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥3.1bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥239.3bnat 2023-06-30Cons.Assets
Total assets¥236.5bnat 2023-03-31Cons.Assets
Total assets¥226.5bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥39.1bnat 2023-06-30Cons.Liabilities
Total liabilities¥40.1bnat 2023-03-31Cons.Liabilities
Net assets / equity¥200.2bnat 2023-06-30Cons.Net assets
Net assets / equity¥196.4bnat 2023-03-31Cons.Net assets
Net assets / equity¥189.0bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥75.8bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥76.4bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥23.412023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥86.12022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.392022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio70.7%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio70.3%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio70.7%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 54
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-06-30¥592m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-06-30¥589m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-06-30¥2m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-06-30−¥20m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥447m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥447m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥314m
jpcrp040300-q1r_E00898-000Equipmentreportable segmentrevenue2023-04-01 → 2023-06-30¥3.3bn
jpcrp040300-q1r_E00898-000Equipmentreportable segmentrevenue external2023-04-01 → 2023-06-30¥3.2bn
jpcrp040300-q1r_E00898-000Equipmentreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥79m
jpcrp040300-q1r_E00898-000Equipmentreportable segmentsegment profit2023-04-01 → 2023-06-30−¥126m
jpcrp040300-q1r_E00898-000Medicinereportable segmentrevenue2023-04-01 → 2023-06-30¥13.8bn
jpcrp040300-q1r_E00898-000Medicinereportable segmentrevenue external2023-04-01 → 2023-06-30¥13.4bn
jpcrp040300-q1r_E00898-000Medicinereportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥349m
jpcrp040300-q1r_E00898-000Medicinereportable segmentsegment profit2023-04-01 → 2023-06-30¥2.1bn
jpcrp040300-q1r_E00898-000Processingreportable segmentrevenue2023-04-01 → 2023-06-30¥11.4bn
jpcrp040300-q1r_E00898-000Processingreportable segmentrevenue external2023-04-01 → 2023-06-30¥11.4bn
jpcrp040300-q1r_E00898-000Processingreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥16m
jpcrp040300-q1r_E00898-000Processingreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.5bn
—segment totalrevenue2023-04-01 → 2023-06-30¥28.5bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥28.0bn
—segment totalrevenue intersegment2023-04-01 → 2023-06-30¥444m
—segment totalsegment profit2023-04-01 → 2023-06-30¥3.5bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-06-30¥29.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-06-30¥28.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-06-30¥447m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-06-30¥3.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥796m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥790m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥6m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30¥17m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥425m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥425m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥369m
jpcrp040300-q1r_E00898-000Equipmentreportable segmentrevenue2022-04-01 → 2022-06-30¥3.1bn
jpcrp040300-q1r_E00898-000Equipmentreportable segmentrevenue external2022-04-01 → 2022-06-30¥3.0bn
jpcrp040300-q1r_E00898-000Equipmentreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥56m
jpcrp040300-q1r_E00898-000Equipmentreportable segmentsegment profit2022-04-01 → 2022-06-30−¥194m
jpcrp040300-q1r_E00898-000Medicinereportable segmentrevenue2022-04-01 → 2022-06-30¥12.7bn
jpcrp040300-q1r_E00898-000Medicinereportable segmentrevenue external2022-04-01 → 2022-06-30¥12.4bn
jpcrp040300-q1r_E00898-000Medicinereportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥354m
jpcrp040300-q1r_E00898-000Medicinereportable segmentsegment profit2022-04-01 → 2022-06-30¥1.8bn
jpcrp040300-q1r_E00898-000Processingreportable segmentrevenue2022-04-01 → 2022-06-30¥11.1bn
jpcrp040300-q1r_E00898-000Processingreportable segmentrevenue external2022-04-01 → 2022-06-30¥11.1bn
jpcrp040300-q1r_E00898-000Processingreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥7m
jpcrp040300-q1r_E00898-000Processingreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.6bn
—segment totalrevenue2022-04-01 → 2022-06-30¥26.9bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥26.5bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥419m
—segment totalsegment profit2022-04-01 → 2022-06-30¥3.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥27.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥27.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥425m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥3.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 407
ItemContextValueUnit
Non operating expensesPrior1YTDDuration144000000JPY
Non operating expensesCurrentYTDDuration184000000JPY
Ordinary incomePrior1YTDDuration4156000000JPY
Ordinary incomeCurrentYTDDuration4274000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration37000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration35000000JPY
Gain on sales of investment securities eiPrior1YTDDuration86000000JPY
Gain on sales of investment securities eiCurrentYTDDuration－JPY
Extraordinary incomePrior1YTDDuration123000000JPY
Extraordinary incomeCurrentYTDDuration35000000JPY
Loss on sales and retirement of noncurrent assets elPrior1YTDDuration13000000JPY
Loss on sales and retirement of noncurrent assets elCurrentYTDDuration24000000JPY
Other elPrior1YTDDuration0JPY
Other elCurrentYTDDuration－JPY
Extraordinary lossPrior1YTDDuration13000000JPY
Extraordinary lossCurrentYTDDuration24000000JPY
Income before income taxesPrior1YTDDuration4266000000JPY
Income before income taxesCurrentYTDDuration4285000000JPY
Income taxesPrior1YTDDuration1207000000JPY
Income taxesCurrentYTDDuration1042000000JPY
Profit lossPrior1YTDDuration3059000000JPY
Profit lossCurrentYTDDuration3243000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration565000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration544000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration2493000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration2698000000JPY
Profit lossPrior1YTDDuration3059000000JPY
Profit lossCurrentYTDDuration3243000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-1286000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration1615000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration3748000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration1306000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-37000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-26000000JPY
Share of other comprehensive income of associates accounted for using equity method ociPrior1YTDDuration435000000JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYTDDuration223000000JPY
Other comprehensive incomePrior1YTDDuration2860000000JPY
Other comprehensive incomeCurrentYTDDuration3119000000JPY
Comprehensive incomePrior1YTDDuration5919000000JPY
Comprehensive incomeCurrentYTDDuration6362000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration4151000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration5169000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration1768000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration1193000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E00898-000MedicineReportableSegmentsMember12355000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E00898-000EquipmentReportableSegmentsMember3002000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E00898-000ProcessingReportableSegmentsMember11106000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember26465000000JPY
Revenues from external customersPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember790000000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember27255000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass